Thousands of men have filed testosterone lawsuits against manufacturers
like AbbVie, Allergan, and Endo Pharmaceuticals because of harmful side
effects. Lawsuit claims against testosterone replacement therapy (TRT)
products – which are often prescribed to treat low testosterone levels
(“Low-T”) in men – include an increased risk of blood clots, stroke,
pulmonary embolism, heart disease, and prostate cancer, among other
potentially deadly complications.
Testosterone Dichloroacetate powder
The claims range from design defects and failure to warn about the
potentially dangerous complications testosterone could cause, to
negligence and breach of warranty, both express and implied. Other
claims include false marketing efforts, such as marketing testosterone
treatments for off-label uses not approved by the U.S. Food and Drug
Administration (FDA). Specific claims were made in each individual
lawsuit, as various people have experienced different problems with
testosterone therapy.
Testosterone Products and Companies Being Sued
AndroGel testosterone lawsuits have been extremely high-profile, given
the large number of cases filed against AbbVie Inc., a division of
Abbott Laboratories. However, a number of other products and companies
have also found themselves at the heart of legal claims. Companies like
Endo Pharmaceuticals, GlaxoSmithKline, Actavis, and Eli Lilly and
Company have all been named as defendants in these suits. Some of the
TRT products under litigation are no longer available on the market.
The Wall